FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for the quarter came in at $126 million versus the consensus estimate of $125.97 million.
GUIDANCE:
Core Laboratories sees Q4 2022 EPS of $0.17-$0.21, versus the consensus of $0.17.... More

